[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-361376-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-361376-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","distinct-glycosyltransferase-expression-governs-organ-specific-survival-in-pancreatic-cancer-metastasis","Distinct glycosyltransferase expression governs organ-specific survival in pancreatic cancer metastasis","","Pancreatic ductal adenocarcinoma (PDAC) frequently metastasizes to vital organs, yet the molecular basis of organ-specific metastatic survival remains unclear. This study uses an unbiased transcriptomic screen to identify distinct glycosyltransferase (GT) expression patterns in liver- and lung-tropic PDAC cells, with GCNT3 and B3GNT3 selectively enriched in respective metastatic environments. Validation in human metastatic specimens and proteomic profiling links these GT differences to epithelial-mesenchymal transition and glycoproteome remodeling. Functional models show that loss of GCNT3 or B3GNT3 impairs PDAC proliferation and survival in matching organs, suggesting glycosylation-mediated adaptation as a therapeutic target.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/distinct-glycosyltransferase-expression-governs-organ-specific-survival-in-pancreatic-cancer-metastasis/361376/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/distinct-glycosyltransferase-expression-governs-organ-specific-survival-in-pancreatic-cancer-metastasis/361376.png","ImageObject",300,407,{"name":42,"@type":43},"LangkahRina","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-14","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",7,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What question does the study address about pancreatic cancer metastasis?","Question",{"text":63,"@type":64},"The study investigates how glycosyltransferases (GTs) contribute to organ-specific survival of metastatic PDAC cells.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"Which glycosyltransferases are linked to liver versus lung metastasis?",{"text":68,"@type":64},"GCNT3 is enriched in liver metastatic lesions, while B3GNT3 is enriched in lung metastases.",{"name":70,"@type":61,"acceptedAnswer":71},"How do the findings connect GT differences to metastatic behavior?",{"text":72,"@type":64},"Proteomic profiling associates differential GT expression with epithelial-mesenchymal transition and glycoproteome remodeling in metastatic cells, and functional assays show that losing the relevant GT reduces proliferation and survival in the corresponding organ environment.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},361376,1790325719,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":108,"preview_page_count":33,"preview_urls":145},962090893776,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","[www.nature.com/onc](www.nature.com/onc Oncogene)[ Oncogene](www.nature.com/onc Oncogene)  \nARTICLE OPEN   \nDistinct glycosyltransferase expression governs organ-speciﬁc survival in pancreatic cancer metastasis  \nVenkatesh Varadharaj1, Frank Leon 1, Nivedeta Krishna Kumar 1, Palanisamy Nallasamy 1, Pratima Raut1, Annant Bir Kaur 1, Kirtana Arikath1, Wyatt Petersen2, Sanchita Rauth 1, Neelanjana Gayen1, Zahraa Wajih Alsafwani 1, Poompozhil Mathivanan1, Saravanakumar Marimuthu1, Kavita Mallya1, Madhu Bommideni1, Jesse L. Cox 3, Geoffrey A. Talmon3, Paul M. Grandgenett4, Michael A. Hollingsworth 4, Dominick J. DiMaio3, Jean L. Grem5, Surinder K. Batra 1,4 ✉ and Moorthy P. Ponnusamy 1,4 ✉  \nThis is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply 2026  \n\n|  |  |  |\n| --- | --- | --- |\n|  | Pancreatic ductal adenocarcinoma (PDAC) is among the most lethal cancers, with over 83% of patients presenting metastases to vital organs such as the liver, lungs, and peritoneum. Although glycosylation has been established as a critical factor in PDAC development, little is known about the molecular underpinnings of organ-speciﬁc metastasis. In this study, we investigated the role of glycosyltransferases (GTs) in mediating PDAC metastatic organotropism. Through an unbiased transcriptomic screen, weidentiﬁed distinct GT expression patterns in liver- and lung-tropic PDAC cells. Notably, GCNT3 and B3GNT3 were selectively upregulated in liver and lung-tropic cells, respectively. These mutually exclusive expression patterns were validated in human metastatic PDAC specimens, where GCNT3 was enriched in liver metastatic lesions and B3GNT3 in lung metastases. Proteomic proﬁling revealed that differential expression of these GTs is associated with epithelial-mesenchymal transition and glycoproteome remodeling in metastatic cells. Functional studies using in vitro assays, ex vivo organotypic cultures, and in vivo metastasis models demonstrated that loss of GCNT3 or B3GNT3 impairs the proliferation and survival of PDAC cells in their respective metastatic organ environments. Together, these ﬁndings uncover a glycosylation-based mechanism that facilitates organ-speciﬁc survival of metastatic PDAC cells and highlight glycosyltransferases as potential therapeutic targets for disrupting metastatic adaptation.\u003Cbr>Oncogene (2026) 45:3858–3873; [https://doi.org/10.1038/s41388-026-03896-5](https://doi.org/10.1038/s41388-026-03896-5) |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n\nGraphical Abstract  \n1Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, NE, USA. 2Department of Cancer Research, University of Nebraska Medical Center, Omaha, NE, USA. 3Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE, USA. 4Fred and Pamela Buffett Cancer Center, Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, NE, USA. 5Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE, USA. ✉ email: [sbatra@unmc.edu](sbatra@unmc.edu); [mpalanim@unmc.edu](mpalanim@unmc.edu)  \nReceived: 8 July 2025 Revised: 26 May 2026 Accepted: 29 June 2026  \nPublished online: 30 July 2026  \nINTRODUCTION  \nPDAC remains one of the most lethal malignancies globally and is projected to become the second leading cause of cancer-related fatalities in the United States by 2030 [1, 2]. The ﬁve-year survival rate of patients with PDAC is less than 13%, mainly because it tends to metastasize at an early stage of tumor development, and due to the lack of early detection [3] . By the time PDAC is diagnosed, ~60% of patients already have metastatic cancer at a stage that cannot be surgically removed [4] .  \nA major challenge lies in deciphering the metastatic cascade, particularly the mech","cbCaitUKypH6zV6E","https://ap.wps.com/l/cbCaitUKypH6zV6E","pdf",7413835,16,"English","# Introduction\n## PDAC prognosis and unmet clinical needs\n## Metastatic cascade and organ-specificity challenge\n## Glycosylation and O-glycan involvement in PDAC","[{\"question\":\"What question does the study address about pancreatic cancer metastasis?\",\"answer\":\"The study investigates how glycosyltransferases (GTs) contribute to organ-specific survival of metastatic PDAC cells.\"},{\"question\":\"Which glycosyltransferases are linked to liver versus lung metastasis?\",\"answer\":\"GCNT3 is enriched in liver metastatic lesions, while B3GNT3 is enriched in lung metastases.\"},{\"question\":\"How do the findings connect GT differences to metastatic behavior?\",\"answer\":\"Proteomic profiling associates differential GT expression with epithelial-mesenchymal transition and glycoproteome remodeling in metastatic cells, and functional assays show that losing the relevant GT reduces proliferation and survival in the corresponding organ environment.\"}]","Distinct glycosyltransferase expression governs organ-specific survival in pancreatic cancer metastasis | PDF",1790144106,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/03ca9025584e8a70ff7409f51a0ff14a.webp",983,1305,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9fe8244b0930632e4797ec8c6aa964d7.webp",982,1304,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/cc5056788374643067f8272f4795827a.webp",981,1303,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8b57ff65189567bcbaab990bfa6695bc.webp",980,1301]